Phase I pharmacokinetic and safety trial of reformulated Z 160.
Phase of Trial: Phase I
Latest Information Update: 02 May 2012
At a glance
- Drugs Z 160 (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- 02 May 2012 This trial evaluated a number of formulations of Z 160, and the optimal formulation has been selected for further clinical studies, according to a Zalicus media release.
- 05 Mar 2012 Status changed from recruiting to completed, according to a Zalicus media release.
- 05 Dec 2011 Status changed from planning to recruiting, according to a Zalicus media release.